Jos Lamers appointed member of Elekta's Executive Committee

| Source: Elekta AB Elekta AB 

Jos Lamers appointed member of Elekta's Executive Committee

Press
Release                                                            
Stockholm, Sweden, September 23, 2011

Jos Lamers has been appointed Executive Vice President Brachytherapy
Solutions and a member of Elekta's Executive Committee.

Jos Lamers has been appointed Executive Vice President, Elekta
Brachytherapy Solutions. He joins Elekta through the acquisition of
Nucletron, announced September 15, 2011. His role on Elekta's Executive
Committee begins immediately. Jos Lamers has been Chief Executive
Officer of Nucletron since 2008.

Jos Lamers is 48 years old and has a Masters degree in Human Nutrition
from the University of Wageningen, the Netherlands. He is a
highly-experienced international business executive, with a proven track
record in life sciences and business-to-business fields.

***

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
email: stina.thorman@elekta.com (stina.thorman@elekta.com)
Time zone: CET: Central European

About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide.

Elekta employs around 3,300 employees globally. The corporate
headquarters is located in Stockholm, Sweden, and the company is listed
on the Nordic Exchange under the ticker EKTAb. Website:
www.elekta.com (http://www.elekta.com/)

Attachments